搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
drugdeliverybusiness
17 小时
Fresenius Kabi warns on Ivenix infusion pump valves
The FDA said Fresenius Kabi told customers to remove its Ivenix large-volume infusion pumps from use for repair.
drugdeliverybusiness
22 小时
Qnovia raises $16M to support nicotine inhaler for smoking cessation therapy
Qnovia announced that it raised $16 million in Series B funding to support its inhaled smoking cessation therapy platform.
drugdeliverybusiness
1 天
Tandem makes t:slim X2 insulin pump available with Dexcom G7 in Canada
Tandem Diabetes Care announced today that t:slim X2 insulin pump users in Canada can now access full compatibility with ...
drugdeliverybusiness
2 天
Senseonics highlights early success with Eversense 365 launch
Senseonics (NYSE:SENS) today announced significant progress with the launch of its Eversense 365 continuous glucose monitor ...
drugdeliverybusiness
5 天
NuGen launches needle-free insulin delivery device in Canada
NuGen Medical Devices announced recently that it launched its InsuJet needle-free insulin delivery device in Canada.
drugdeliverybusiness
6 天
Embecta to lay off 118 in Massachusetts following patch pump program discontinuation
Embecta (Nasdaq:EMBC) filed with the state of Massachusetts to confirm a workforce reduction affecting 118 employees.
drugdeliverybusiness
6 天
Cardinal Health recalls certain insulin syringe component packs
The FDA deemed a recall of Cardinal Health (NYSE:CAH) insulin syringe luer lock packs as type I, the most serious kind of ...
drugdeliverybusiness
6 天
Insulet prevails in IP battle with patch pump maker EOFlow
Insulet (Nasdaq:PODD) announced that it successfully defended its intellectual property against EOFlow in U.S. federal court.
drugdeliverybusiness
8 天
Glucotrack begins enrollment for first human trial of continuous blood glucose monitor
Glucotrack (Nasdaq:GCTK) announced today that it commenced patient enrollment for its short-term human clinical study.
drugdeliverybusiness
9 天
Modular Medical brings in $8.2M
Modular Medical (Nasdaq:MODD) announced recently that it priced an underwritten public offering worth proceeds of around $8.2 ...
drugdeliverybusiness
14 天
Embecta discontinues insulin patch pump program, plans restructuring
Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈